Rituximab Noninferior to Cyclosporine in Membranous Nephropathy

WEDNESDAY, July 17, 2019 -- In patients with membranous nephropathy at high risk for progressive disease, rituximab is noninferior to cyclosporine in inducing complete or partial remission of proteinuria at 12 months and is superior in maintaining...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news